![Vincent Mutel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vincent Mutel
Algemeen Directeur bij Inflamalps SA
Profiel
Vincent Mutel was the founder of Addex Therapeutics Ltd.
(founded in 2002) where he held the title of Chief Executive Officer from 2002 to 2010.
He is also the founder of Inflamalps SA (founded in 2012) where he currently holds the title of Chairman & Chief Executive Officer.
Dr. Mutel's current job is as a Director at Metys Pharmaceuticals AG.
His former jobs include being a Non-Executive Director at Lectus Therapeutics Ltd., Head-Pharmacology at F.
Hoffmann-La Roche Ltd., Principal at Basel - SpA, and Principal at CRI Worldwide LLC.
Dr. Mutel obtained a doctorate degree from the University of Paris Jussieu in 1987.
Actieve functies van Vincent Mutel
Bedrijven | Functie | Begin |
---|---|---|
Inflamalps SA
![]() Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands. | Algemeen Directeur | 01-08-2012 |
Metys Pharmaceuticals AG
![]() Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Vincent Mutel
Bedrijven | Functie | Einde |
---|---|---|
CRI Worldwide LLC
![]() CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
![]() Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - |
Basel - SpA
![]() Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Corporate Officer/Principal | - |
ADDEX THERAPEUTICS LTD | Oprichter | - |
Opleiding van Vincent Mutel
University of Paris Jussieu | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Basel - SpA
![]() Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Miscellaneous |
Lectus Therapeutics Ltd.
![]() Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
CRI Worldwide LLC
![]() CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Commercial Services |
Inflamalps SA
![]() Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands. | Health Technology |
Metys Pharmaceuticals AG
![]() Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Health Technology |